Stock Track | Pharvaris N.V. Soars 5.09% Intraday on Bullish Analyst Ratings

Stock Track
May 14

Shares of Pharvaris N.V. (PHVS) surged 5.09% during intraday trading on Wednesday, marking a significant upward movement for the healthcare stock.

The sharp rise appears to be driven by a wave of positive analyst sentiment. Multiple financial institutions have recently issued or reaffirmed bullish ratings on the company. RBC Capital reiterated its Buy rating on Pharvaris, accompanied by a price target of $51.00. Separately, Citizens maintained its Market Outperform rating on the stock.

Further reinforcing the optimistic outlook, several financial news reports highlighted that analysts are bullish on Pharvaris, grouping it with other top healthcare stocks. This collective analyst confidence is a key factor behind the stock's strong performance in the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10